Overview

Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp

Status:
Terminated

Trial end date:
2014-12-21

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the safety and efficacy of intravenous micafungin for the treatment of adult patients in China infected by Candida spp or Aspergillus spp.

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma China, Inc.

Treatments:

Echinocandins
Micafungin